Moleculin (MBRX) Prices 7 04M Share Offering at $0 64/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report released on Thursday, Benzinga reports. The brokerage issued a buy rating and a $3.00 target price on the stock. Separately, StockNews.com initiated coverage on Moleculin Biotech in a research report on Thursday, December 7th. They issued a sell rating […]
Moleculin Biotech (NASDAQ:MBRX) Receives New Coverage from Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Research analysts at HC Wainwright initiated coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a note issued to investors on Thursday, Benzinga reports. The brokerage set a “buy” rating and a $3.00 price target on the stock. HC Wainwright’s price target points to a potential upside of 469.26% from the company’s […]
HOUSTON - Moleculin Biotech, Inc., , a clinical stage pharmaceutical company with a growing pipeline, including Phase 2 clinical programs, for hard-to-treat tumors and viruses, today announced the.